Brain and Acute Leukemia, Cytoplasmic (BAALC) Peptide
BAALC
Reactivité: Humain, Souris, Porc, Rat
Hôte: Synthetic
BP, Imm
-
- Antigène Tous les produits BAALC
- BAALC (Brain and Acute Leukemia, Cytoplasmic (BAALC))
- Origine
- Humain, Souris, Porc, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Séquence
- KQNGLQTTEA KRDAK
- Attributs du produit
- The peptide was used in the production of ABIN369346 - Goat Anti-BAALC Antibody. It is currently untested in blocking applications.
-
-
- Indications d'application
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Stock
- -20 °C
- Stockage commentaire
- Shipped at ambient temperature, store at -20°C.
-
- Antigène
- BAALC (Brain and Acute Leukemia, Cytoplasmic (BAALC))
- Synonymes
- si:zc215i13.3 Peptide, si:ch211-215i13.3 Peptide, BAALC Peptide, 2810457D07Rik Peptide, BAALC, MAP3K1 and KLF4 binding Peptide, brain and acute leukemia, cytoplasmic Peptide, BAALC Peptide, baalc Peptide, Baalc Peptide
-
Vous êtes ici:
